When researchers inserted the Neanderthal GHR into lab-grown cells (both human and mouse cell lines) and exposed them to growth hormone:
The Neanderthal receptor produces a stronger intracellular signaling response when bound by growth hormone, making cells more sensitive to growth signals .
In a large-scale analysis of over 1.1 million adults, carriers of the Neanderthal GHR variant averaged:
The variant is absent in people from sub-Saharan Africa, since Neanderthal admixture occurred after the Out-of-Africa migration . Among non-African populations, carrier frequencies are:
About 94% of sequenced Neanderthal genomes carried the variant, compared to fewer than 10% of modern humans globally .
The Neanderthal GHR variant entered modern human gene pools through interbreeding between Neanderthals and the ancestors of non-African modern humans, estimated at around 47,000 years ago .
Beyond muscle mass, the Neanderthal GHR variant is linked to subtle changes in skeletal morphology, including:
The lead researchers emphasized that the effect, while statistically significant, is modest at the population level — roughly a quarter-kilogram of extra muscle and a few millimeters of extra height . They cautioned that the variant is not a "super-muscle gene" that produces dramatic physique differences. Instead, it represents a small, accumulated effect from ancient introgression that only becomes detectable in large-scale cohort studies
. The study's authors also noted that the variant's functional significance should not be overstated, as many other genetic and environmental factors contribute far more to individual variation in muscle mass
.